Pluri Inc. Shares Drop 3.81% as Investors Eye MSC Therapy Outlook
Pluri Inc. (PLUR) shares dip 3.81% as the company’s MSC tech faces short‑term volatility, but strong clinical progress and partnerships could boost future value.
2 minutes to read
PLURI INC
Pluri Inc. Shares Surge 16.7% After New Deal with Chutzpah Holdings, Market Cap Hits $11.7M
Pluri Inc. (PLUR) jumps 16.7% as it signs a share‑and‑warrant deal with Chutzpah Holdings, boosting a biotech firm focused on stem‑cell therapies.
2 minutes to read
Pluri Inc. Surges 5.9% as Private Deal Fuels Growth Amid Biotech Volatility
Pluri Inc. sees a 5.9% rally amid a risky private deal with Chutzpah Holdings LP, raising questions on liquidity and MSC tech valuation.
4 minutes to read